Please assess the completion status of the following clinical trial:

Trial Title: Fixed Dose Heparin Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A diagnosis of acute venous thromboembolism (VTE,DVT and /or PE)~Exclusion Criteria:~* Contraindication to subcutaneous (sc) route of administration (eg:shock (evidence of poor peripheral perfusion), major surgery within 48 hours)~* Active Bleeding process~* Comorbid condition limiting expected survival to less than 3 months~* Current treatment with therapeutic dose of UFH, LMWH, danaparoid sodium, or a direct thrombin inhibitor for more than 48 hours~* Currently on long term warfarin or heparin therapy~* Allergy to heparin or history of heparin induced thrombocytopenia~* Currently pregnant~* Contraindication to contrast media (eg: allergy or creatinine \>200 umol/L).~* Currently enrolled or will be enrolled in a competing study~* Geographically inaccessible for follow-up assessment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).